調查台灣透析患者尿路上皮細胞癌和腎腫瘤的初步診斷時間- 全國人口基數隊列研究
高建璋、查岱龍、孫光煥、于大雄、張聖原、吳勝堂
三軍總醫院 外科部 泌尿科
To investigate the duration of initial diagnosis of urothelial cell carcinoma and renal tumor in Taiwan patients with dialysis – a nationwide population-based cohort study
Chien-Chang Kao, Dai-Lung Cha, Guang-Huan Sun, Dah-Shyong Yu,
Sun-Yran Chang, Sheng-Tang Wu
Divisions of Urology, Department of Surgery, Tri-service general hospital, National Defense Medical Center, Taiwan
Abstract
Aim: The cohort study declared the duration time of first tumor diagnosis in those dialysis patients in Taiwan.
Methods: The authors analyzed the Taiwan Longitudinal Health Insurance Database, which is randomly abstracted from the National Health Insurance Research Database from 2000 to 2013. Demographic data and tumor incidence were analyzed.
Results: Of 11820 dialysis patients (study cohort group), 134 (1.13%) had been diagnosed with renal cancer or urothelial cell cancer of renal pelvic and bladder. In the study cohort group, average time to renal cancer or urothelial cell carcinoma was 4.18 +/- 4.06 years. Further, we performed subgroup analysis, 4.11 +/- 3.97 years in hemodialysis patients, then 4.39 +/- 4.20 years in peritoneal dialysis patients.
Conclusion: The known duration time to cancer diagnosis in those dialysis patients was very important due to no urine output for examinations. By means of the cohort studies, much more attentions should be warranted to teaching clinician to arrange regular cancer screening, like ultrasound of abdomen or cystoscopy or intraveneous pyelography.